The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000173.7(GP1BA):c.624del (p.Phe208fs)

CA287216329

3582323 (ClinVar)

Gene: GP1BA (HGNC:2811)
Condition: Bernard-Soulier syndrome (MONDO:0009276)
Inheritance Mode: Autosomal recessive inheritance
UUID: 2326b0f9-7567-45bd-8ccc-5fc415c6b06f
Approved on: 2025-12-16
Published on: 2025-12-16

HGVS expressions

NM_000173.7(GP1BA):c.624del (p.Phe208fs)
NM_000173.7:c.624del
NC_000017.11:g.4933228del
CM000679.2:g.4933228del
NC_000017.10:g.4836523del
CM000679.1:g.4836523del
NC_000017.9:g.4777303del
NG_008767.2:g.5934del
ENST00000329125.6:c.624del
ENST00000649830.1:c.-888+1119del
ENST00000329125.5:c.624del
ENST00000611961.1:c.624del
NM_000173.6:c.624del
More

Likely Pathogenic

Met criteria codes 4
PM3_Supporting PM2_Supporting PVS1_Strong PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Platelet Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GP1BA Version 1.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Platelet Disorders VCEP
The c.624del (p.Phe208LeufsTer48) variant in GP1BA is a nonsense variant that may cause loss of function of the protein, however it is predicted to escape nonsense mediated decay and remove >10% of the protein (PVS1_Strong). At least one patient (Patient BSS-2 in PMID:23300803) with this variant had aggregation absent for ristocetin and present for all other agonists as well as less than 10% expression of GPIba measured by flow cytometry, which is highly specific for Bernard-Soulier syndrome Additionally, the patient had macrothrombocytopenia which is consistent with Bernard-Soulier syndrome (PP4). This individual was homozygous for the variant (0.5 PM3 points, PM3_Supporting). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive Bernard-Soulier syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PVS1_Strong, PP4, PM3_Supporting and PM2_Supporting (VCEP specifications version 1.1).
Met criteria codes
PM3_Supporting
This variant has been detected in at least 1 proband with Bernard-Soulier syndrome (Patient BSS-2 in PMID:23300803). This individual was homozygous for the variant (0.5 PM3 points, PM3_Supporting).
PM2_Supporting
This variant is absent from gnomAD v4.1.0 (PM2_Supporting).
PVS1_Strong
The c.624del (p.Phe208LeufsTer48) variant in GP1BA is a nonsense variant that may cause loss of function of the protein, however it is predicted to escape nonsense mediated decay and remove >10% of the protein (PVS1_Strong).
PP4
At least one patient (Patient BSS-2 in PMID:23300803) with this variant had aggregation absent for ristocetin and present for all other agonists as well as less than 10% expression of GPIba measured by flow cytometry, which is highly specific for Bernard-Soulier syndrome Additionally, the patient had macrothrombocytopenia which is consistent with Bernard-Soulier syndrome (PP4).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.